Login / Signup

A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis.

Mohammad Ali NilforooshzadehNazila HeidariYekta GhaneAmirhossein HeidariArman Hajikarim-HamedaniSeyedayin HosseiniFariba JaffaryMinou Najar NobariPegah TavakolzadehNiloufar Najar Nobari
Published in: Inflammopharmacology (2024)
IL-31 inhibitors suggest distinct advantages in improving pruritus, sleep quality, and overall quality of life in subjects with moderate-to-severe PN. Further clinical studies are recommended to compare the effectiveness of these biologics to other therapeutic choices.
Keyphrases
  • sleep quality
  • depressive symptoms
  • randomized controlled trial
  • systematic review
  • physical activity
  • early onset
  • drug induced
  • replacement therapy
  • smoking cessation